Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind vehicle-controlled study of DVC-01 cream for eczema
CTR20190509Phase 3Active
- Sponsor
- Tianjin Pharmaceutical Research Institute
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DVC-01 in atopic dermatitis (AD), sponsored by Tianjin Pharmaceutical Research Institute. Started Mar 2019; status: active.
02
Drugs
DVC-01
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20190509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190509.